Exerkine Fibronectin Type-Iii Domain-Containing Protein 5/Irisin-Enriched Extracellular Vesicles Delay Vascular Ageing by Increasing SIRT6 Stability.
Chen Chi,Hui Fu,Yong-Hua Li,Guo-Yan Zhang,Fei-Yan Zeng,Qing-Xin Ji,Qi-Rui Shen,Xu-Jie Wang,Zi-Chen Li,Can-Can Zhou,Di-Yang Sun,Jiang-Tao Fu,Wen-Bin Wu,Ping-Ping Zhang,Jia-Bao Zhang,Jian Liu,Fu-Ming Shen,Dong-Jie Li,Pei Wang
DOI: https://doi.org/10.1093/eurheartj/ehac431
IF: 39.3
2022-01-01
European Heart Journal
Abstract:AIMS:Exercise confers protection against cardiovascular ageing, but the mechanisms remain largely unknown. This study sought to investigate the role of fibronectin type-III domain-containing protein 5 (FNDC5)/irisin, an exercise-associated hormone, in vascular ageing. Moreover, the existence of FNDC5/irisin in circulating extracellular vesicles (EVs) and their biological functions was explored.METHODS AND RESULTS:FNDC5/irisin was reduced in natural ageing, senescence, and angiotensin II (Ang II)-treated conditions. The deletion of FNDC5 shortened lifespan in mice. Additionally, FNDC5 deficiency aggravated vascular stiffness, senescence, oxidative stress, inflammation, and endothelial dysfunction in 24-month-old naturally aged and Ang II-treated mice. Conversely, treatment of recombinant irisin alleviated Ang II-induced vascular stiffness and senescence in mice and vascular smooth muscle cells. FNDC5 was triggered by exercise, while FNDC5 knockout abrogated exercise-induced protection against Ang II-induced vascular stiffness and senescence. Intriguingly, FNDC5 was detected in human and mouse blood-derived EVs, and exercise-induced FNDC5/irisin-enriched EVs showed potent anti-stiffness and anti-senescence effects in vivo and in vitro. Adeno-associated virus-mediated rescue of FNDC5 specifically in muscle but not liver in FNDC5 knockout mice, promoted the release of FNDC5/irisin-enriched EVs into circulation in response to exercise, which ameliorated vascular stiffness, senescence, and inflammation. Mechanistically, irisin activated DnaJb3/Hsp40 chaperone system to stabilize SIRT6 protein in an Hsp70-dependent manner. Finally, plasma irisin concentrations were positively associated with exercise time but negatively associated with arterial stiffness in a proof-of-concept human study.CONCLUSION:FNDC5/irisin-enriched EVs contribute to exercise-induced protection against vascular ageing. These findings indicate that the exerkine FNDC5/irisin may be a potential target for ageing-related vascular comorbidities.